Vitality in Aging Research Group

Vitality in Aging Research Group (ViAging) is a non-profit research organization dedicated to advancing longevity science and healthy aging. Founded in 2019 by Bill Faloon and Brian Delaney, the group conducts large-scale longitudinal studies and clinical intervention trials to identify biomarkers of aging and evaluate the efficacy of anti-aging treatments. Their primary initiatives include the VIA Longitudinal Study, modeled after the Framingham Heart Study, and the VIA Interventions Trial, which tests compounds such as senolytics and mTOR inhibitors. The organization aims to compress morbidity and extend human healthspan by targeting the root biological causes of age-related decline through rigorous clinical data collection.